Abstract:Liandan Xiaoyan Formula (LDXYF) is a traditional Chinese medicine prescription (TCMP) consisting of Herba Andrographis (dried herb of Andrographis paniculata) and Picrasmae ramulus et folium (dried twiggeries and leaves of Picrasma quassioides). It is used to treat diarrhea, acute gastroenteritis, colitis, and dysentery, among other inflammatory gastrointestinal diseases. However, because of less research on the in vitro chemical composition and holistic metabolism of LDXYF, in vivo mechanisms of action and quality control of LDXYF have not yet been fully assessed due to the lack of studies into its bioactive components. In this study, ultra-performance liquid chromatography coupled with quadruple time-of-flight mass spectrometry (UPLC-Q-TOF-MS) was established for comprehensive analysis of chemical compounds of LDXYF and their metabolites in serum and urine samples of control and colitis rats. As a result, totally 94 compounds in LDXYF were unambiguously identified or tentatively characterized. And a total of 91 LDXYF-related xenobiotics were characterized, including 61 (16 prototypes and 45 metabolites) in serum, and 72 (26 prototypes and 46 metabolites) in urine. Besides, we compared the exposure of metabolites in normal and colitis rats by chemometrics and summarize similarities and differences of metabolic pathways of mainly compounds in normal and colitis conditions, and found that in control and colitis conditions, alkaloids predominantly went through phase I reaction combined phase II reaction (hydroxylation and sulfation, hydroxylation and glucuronidation, demethylation and glucuronidation), while the major metabolic reaction of diterpene lactones were phase II reactions (glucuronidation, sulfation). And there were no significant differences in metabolic pathways between control and colitis groups, just the exposure of prototype and their metabolites absorbed into serum or excreted through the urine were different, and 17 alkaloids and 6 diterpene lactone prototypes and their metabolites in serum could be considered as potential pharmacodynamic substances. A comprehensive analysis of the compounds and metabolic characteristics of LDXYF was conducted in our study, and the results laid the chemical foundation for further research into effective substances and the action mechanism of LDXYF.

Development of Rat Urinary HPLC-UV Profiling for Metabonomic Study on Liuwei Dihuang Pills

[Estimation of Effects of Liuwei Dihuang Wan on Anti-Inflammation in Rat by HPLC-UV Based Metabonomic Method].

Application of Metabonomic Strategy to Discover an Unreported Active Ingredient in LiuWeiDiHuang Pills Suppressing Beta-Glucuronidase.

Metabolites identification of Huo Luo Xiao Ling Dan in rat urine by UPLC coupled with electrospray ionization time‐of‐flight mass spectrometry

Urinary Metabolomics on the Biochemical Profiles in Diet-Induced Hyperlipidemia Rat Using Ultraperformance Liquid Chromatography Coupled with Quadrupole Time-of-Flight SYNAPT High-Definition Mass Spectrometry.

An integrated strategy to delineate the chemical and dynamic metabolic profile of Huachansu tablets in rat plasma based on UPLC-ESI-QTOF/MS E

Identification of metabolites of Buyang Huanwu decoction in rat urine using liquid chromatography-quadrupole time-of-flight mass spectrometry

The Profiling of the Metabolites of Hirsutine in Rat by Ultra-High Performance Liquid Chromatography Coupled with Linear Ion Trap Orbitrap Mass Spectrometry: an Improved Strategy for the Systematic Screening and Identification of Metabolites in Multi-Samples in Vivo

Biological Ingredient Analysis of Traditional Chinese Medicine Preparation Based on High-Throughput Sequencing: the Story for Liuwei Dihuang Wan.

A Combination of Representative Compounds, Metabolism Platform and Diagnostic Extraction Strategy for Characterization of Metabolites of Shuang-Huang-Lian Oral Liquid in Vivo by Ultra-Performance Liquid Chromatography Coupled with Time-of-flight Mass Spectrometry.

A comparative study of Liandan Xiaoyan Formula metabolic profiles in control and colitis rats by UPLC-Q-TOF-MS combined with chemometrics

Chemical fingerprinting of Liuwei Dihuang Pill and simultaneous determination of its major bioactive constituents by HPLC coupled with multiple detections of DAD, ELSD and ESI-MS.

Characterization of chemical constituents and metabolites in rat plasma after oral administration of San Miao Wan by ultra-high performance liquid chromatography tandem Q-Exactive Orbitrap mass spectrometry

Identification of metabolites of Danggui Buxue Tang in rat urine by liquid chromatography coupled with electrospray ionization time&hyphen;of&hyphen;flight mass spectrometry

A simple HPLC method for simultaneous analysis of 7 bioactive constituents for Liuwei Dihuang Pill and its application in quality consistency evaluation

Characterization of chemical ingredients and in rats metabolic profiling of Lingyang Qingfei pills via ultra‐high‐performance liquid chromatography combined with Quadrupole‐Exactive Orbitrap high‐resolution mass spectrometry

An integrating strategy for systematic profiling of Chinese patent drug's chemicalome and associated metabolome: Huanghou antidiarrhea dropping pills as a case study

Identification of metabolites of Danggui Buxue Tang in rat urine by liquid chromatography coupled with electrospray ionization time-of-flight mass spectrometry.

Sensitive profiling of phenols, bile acids, sterols, and eicosanoids in mammalian urine by large volume direct injection-online solid phase extraction-ultra high performance liquid chromatography-polarity switching tandem mass spectrometry

Identification of the Constituents and Metabolites in Rat Plasma after Oral Administration of HuanglianShangqing Pills by Ultra High-Performance Liquid Chromatography/quadrupole Time-of-flight Mass Spectrometry.

Characterization of Global Metabolic Profile of Zhi-Zi-Hou-Po Decoction in Rat Bile, Urine and Feces after Oral Administration Based on a Strategy Combining LC–MS and Chemometrics